MedPath

Attention Defficity Hyperactivity Disorder and fMRI neurofeedback: A randomized controlled trial on the effects of self-modulating anterior cingulate cortex activation levels.

Phase 2
Recruiting
Conditions
Attention Deficit Hyperactivity Disorder
10009841
Registration Number
NL-OMON37512
Lead Sponsor
niversitair Medisch Centrum Sint Radboud
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.) Diagnosis of ADHD according to the DSM-IV TR criteria
2.) fMRI screening criteria
3.) Age > 18
4.) IQ > 85
5.) Psychopharmaca-naïve or -free, or being on a fixed dose of medication for the study period

Exclusion Criteria

1.) Current diagnosis of one or more Axis I diagnosis other than ADHD according to the DSM-IV TR criteria
2.) Other significant medical condition/ regular use of medication other than psychostimulants
3.) Participation in another clinical trial simultaneously

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath